BioCorRx Inc. (BICX)
USD 0.43
(-14.0%)
USD 0.43
(-14.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.63 Million USD | 235.85% |
| 2022 | 1.67 Million USD | 1.51% |
| 2021 | 1.65 Million USD | 72.96% |
| 2020 | 955.58 Thousand USD | 17.0% |
| 2019 | 816.72 Thousand USD | -81.28% |
| 2018 | 4.36 Million USD | 98.08% |
| 2017 | 2.2 Million USD | 89.99% |
| 2016 | 1.15 Million USD | -34.04% |
| 2015 | 1.75 Million USD | 129.76% |
| 2014 | 764.93 Thousand USD | -15.78% |
| 2013 | 908.25 Thousand USD | 795.33% |
| 2012 | 101.44 Thousand USD | -47.13% |
| 2011 | 191.89 Thousand USD | 0.0% |
| 2010 | - USD | -100.0% |
| 2009 | 280.00 USD | 0.0% |
| 2008 | 280.00 USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 6.21 Million USD | -64.8% |
| 2024 Q1 | 6.12 Million USD | 8.69% |
| 2023 Q1 | 1.89 Million USD | 12.97% |
| 2023 Q3 | 1.63 Million USD | 4.3% |
| 2023 FY | 5.63 Million USD | 235.85% |
| 2023 Q4 | 5.63 Million USD | 243.75% |
| 2023 Q2 | 1.57 Million USD | -17.08% |
| 2022 Q1 | 4.6 Million USD | 178.76% |
| 2022 Q3 | 1.32 Million USD | -16.72% |
| 2022 Q2 | 1.59 Million USD | -65.39% |
| 2022 FY | 1.67 Million USD | 1.51% |
| 2022 Q4 | 1.67 Million USD | 26.35% |
| 2021 FY | 1.65 Million USD | 72.96% |
| 2021 Q4 | 1.65 Million USD | -1.66% |
| 2021 Q3 | 1.68 Million USD | 66.84% |
| 2021 Q2 | 1 Million USD | 11.68% |
| 2021 Q1 | 902.02 Thousand USD | -5.61% |
| 2020 Q2 | 812.28 Thousand USD | 1.77% |
| 2020 Q3 | 980.36 Thousand USD | 20.69% |
| 2020 FY | 955.58 Thousand USD | 17.0% |
| 2020 Q4 | 955.58 Thousand USD | -2.53% |
| 2020 Q1 | 798.19 Thousand USD | -2.27% |
| 2019 Q1 | 4.79 Million USD | 9.8% |
| 2019 Q4 | 816.72 Thousand USD | 35.13% |
| 2019 Q3 | 604.38 Thousand USD | -88.28% |
| 2019 Q2 | 5.15 Million USD | 7.62% |
| 2019 FY | 816.72 Thousand USD | -81.28% |
| 2018 Q4 | 4.36 Million USD | 22.37% |
| 2018 Q2 | 3.18 Million USD | 13.69% |
| 2018 Q1 | 2.8 Million USD | 27.26% |
| 2018 FY | 4.36 Million USD | 98.08% |
| 2018 Q3 | 3.56 Million USD | 11.88% |
| 2017 Q2 | 1.45 Million USD | 31.29% |
| 2017 Q3 | 1.82 Million USD | 25.84% |
| 2017 Q4 | 2.2 Million USD | 20.53% |
| 2017 FY | 2.2 Million USD | 89.99% |
| 2017 Q1 | 1.1 Million USD | -4.59% |
| 2016 Q2 | 1.05 Million USD | -0.9% |
| 2016 Q3 | 884.7 Thousand USD | -15.74% |
| 2016 FY | 1.15 Million USD | -34.04% |
| 2016 Q4 | 1.15 Million USD | 31.04% |
| 2016 Q1 | 1.05 Million USD | -39.71% |
| 2015 Q1 | 764.14 Thousand USD | -0.1% |
| 2015 Q2 | 1.77 Million USD | 132.15% |
| 2015 Q3 | 1.79 Million USD | 1.46% |
| 2015 Q4 | 1.75 Million USD | -2.35% |
| 2015 FY | 1.75 Million USD | 129.76% |
| 2014 Q2 | 609.53 Thousand USD | -37.4% |
| 2014 Q1 | 973.72 Thousand USD | 7.21% |
| 2014 Q3 | 790.04 Thousand USD | 29.61% |
| 2014 Q4 | 764.93 Thousand USD | -3.18% |
| 2014 FY | 764.93 Thousand USD | -15.78% |
| 2013 Q1 | 436.26 Thousand USD | 330.06% |
| 2013 Q3 | 301.53 Thousand USD | -55.84% |
| 2013 Q4 | 908.25 Thousand USD | 201.21% |
| 2013 FY | 908.25 Thousand USD | 795.33% |
| 2013 Q2 | 682.8 Thousand USD | 56.51% |
| 2012 Q2 | 301.46 Thousand USD | 37.92% |
| 2012 FY | 101.44 Thousand USD | -47.13% |
| 2012 Q4 | 101.44 Thousand USD | -58.27% |
| 2012 Q1 | 218.58 Thousand USD | 13.91% |
| 2012 Q3 | 243.09 Thousand USD | -19.36% |
| 2011 Q1 | 10 Thousand USD | 0.0% |
| 2011 Q3 | 16.31 Thousand USD | 0.0% |
| 2011 Q2 | 16.31 Thousand USD | 63.13% |
| 2011 FY | 191.89 Thousand USD | 0.0% |
| 2011 Q4 | 191.89 Thousand USD | 1076.31% |
| 2010 Q1 | 100.00 USD | -64.29% |
| 2010 Q3 | 100.00 USD | 0.0% |
| 2010 Q4 | - USD | -100.0% |
| 2010 FY | - USD | -100.0% |
| 2010 Q2 | 100.00 USD | 0.0% |
| 2009 Q2 | 100.00 USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2009 FY | 280.00 USD | 0.0% |
| 2009 Q4 | 280.00 USD | 180.0% |
| 2009 Q3 | 100.00 USD | 0.0% |
| 2008 FY | 280.00 USD | 0.0% |
| 2008 Q1 | 100.00 USD | 0.0% |
| 2008 Q4 | 280.00 USD | 180.0% |
| 2008 Q3 | 100.00 USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| The Amacore Group, Inc. | 2.85 Million USD | -97.537% |
| Arem Pacific Corporation | 224.41 Thousand USD | -2410.829% |
| Assisted 4 Living, Inc. | 43.05 Thousand USD | -12986.973% |
| Bionik Laboratories Corp. | 2.41 Million USD | -133.582% |
| Banyan Corp. | 3.65 Million USD | -53.978% |
| Clearday, Inc. | 45.06 Million USD | 87.496% |
| Dental Patient Care America, Inc. | 27 Thousand USD | -20768.586% |
| Quantum Medical Transport, Inc. | 1097.80 USD | -513174.458% |
| Empower Clinics Inc. | 2.49 Million USD | -126.113% |
| First Choice Healthcare Solutions, Inc. | 23.24 Million USD | 75.757% |
| Selectis Health, Inc. | 37.24 Million USD | 84.872% |
| Ethema Health Corporation | 14.58 Million USD | 61.361% |
| HealthLynked Corp. | 1.97 Million USD | -185.484% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 14.45 Million USD | 61.012% |
| JRSIS Health Care Corporation | 1.02 Million USD | -447.089% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 116.21 Million USD | 95.151% |
| MedSmart Group Inc. | 788.04 Thousand USD | -615.027% |
| North America Frac Sand, Inc. | 275 Thousand USD | -1948.992% |
| Nova Leap Health Corp. | 208.23 Thousand USD | -2605.894% |
| Nexteligent Holdings, Inc. | 1.88 Million USD | -199.634% |
| PAO Group, Inc. | 639.95 Thousand USD | -780.495% |
| Primemd Inc. | 7.13 Million USD | 21.015% |
| Raffles Medical Group Ltd | 65.87 Million USD | 91.446% |
| Ryman Healthcare Limited | 1.53 Billion USD | 99.633% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.34 Million USD | -317.892% |
| Mycotopia Therapies, Inc. | 1.09 Million USD | -416.639% |
| U.S. NeuroSurgical Holdings, Inc. | 85 Thousand USD | -6529.091% |
| Veltex Corporation | 2.18 Million USD | -157.899% |
| World Financial Holding Group | 98.4 Thousand USD | -5626.058% |
| Xcelerate Inc. | 1.42 Million USD | -296.59% |